After surviving Coronavirus Disease 2019 (COVID-19), some people develop symptoms known as post-acute sequelae of COVID-19 (PASC). PASC is an emerging phenomenon yet to be fully understood, and identifying risk factors has been challenging.

A substantial proportion of patients suffer from Post-COVID Syndrome (PCS) with fatigue and impairment of memory and concentration being the most important symptoms.

Some children and young people (CYP) infected with SARS-COV-2 experience impairing symptoms post-infection, known as post-COVID-19 condition (PCC).

Patients suffering from post-COVID syndrome generally feel supported by their general practitioners; they take their complaints seriously and actively collaborate on finding solutions.

By March, 2023, 54 countries, areas, and territories (hereafter CAT) in the WHO European Region had reported more than 2·2 million COVID-19-related deaths to the WHO Regional Office for Europe.

The recent global COVID-19 pandemic has had a profound and enduring impact, resulting in substantial loss of life.

It is estimated that 6% of American adults currently suffer from persistent symptoms that can linger for weeks to years after COVID-19 infection.

Representatives of EU Member States agreed on the launch of a call for best and promising practices on prevention, mapping of prevention policies and updating the Healthier Together guidance document by including new focus on lifelong prevention.